<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Congenital contractural <z:hpo ids='HP_0001166'>arachnodactyly</z:hpo> (CCA) is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> condition that shares skeletal features with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>), but does not have the ocular and cardiovascular complications that characterize <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>CCA and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> result from mutations in highly similar genes, FBN2 and FBN1, respectively </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the identified CCA mutations in FBN2 cluster in a limited region similar to where severe <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> mutations cluster in FBN1, specifically between exons 23 and 34 </plain></SENT>
<SENT sid="3" pm="."><plain>We screened exons 22 through 36 of FBN2 for mutations in 13 patients with classic CCA by single stranded conformational polymorphism analysis (SSCP) and then by direct sequencing </plain></SENT>
<SENT sid="4" pm="."><plain>We successfully identified 10 novel mutations in this critical region of FBN2 in these patients, indicating a mutation detection rate of 75% in this limited region </plain></SENT>
<SENT sid="5" pm="."><plain>Interestingly, none of these identified FBN2 mutations alter amino acids in the calcium binding consensus sequence in the EGF-like domains, whereas many of the FBN1 mutations alter the consensus sequence </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, analysis of the clinical data of the CCA patients with characterized FBN2 mutation indicate that CCA patients have <z:hpo ids='HP_0002616'>aortic root dilatation</z:hpo> and the vast majority lack evidence of <z:hpo ids='HP_0002564'>congenital heart disease</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>These studies have implications for our understanding of the molecular basis of CCA, along with the diagnosis and genetic counseling of CCA patients </plain></SENT>
</text></document>